pe
pep-05264 v1 CC-BY-SA-4.0

SPAG11B cancer-fighting peptide

An experimental peptide studied in the lab for its ability to fight cancer cells; not yet an approved drug.

statusbioassayed targetANTICANCER length53 aa refs1
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.392
avg pLDDT46.7
ranking score0.452
STRUCTURE · PEP-05264 × ANTICANCER
ranking0.452
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence53 aa
1510152025303540455053
APIIRRIPYYPEVESDLR IVDCKRSEGFCQEYCNYL ETQVGYCSKKKDACCLH
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.4519224166870117 boltz-2
3-letter notation
Ala-Pro-Ile-Ile-Arg-Arg-Ile-Pro-Tyr-Tyr-Pro-Glu-Val-Glu-Ser-Asp-Leu-Arg-Ile-Val-Asp-Cys-Lys-Arg-Ser-Glu-Gly-Phe-Cys-Gln-Glu-Tyr-Cys-Asn-Tyr-Leu-Glu-Thr-Gln-Val-Gly-Tyr-Cys-Ser-Lys-Lys-Lys-Asp-Ala-Cys-Cys-Leu-His
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). SPAG11B cancer-fighting peptide (pep-05264, v1). PeptideModel. https://peptidemodel.com/card/pep-05264
@peptide{pep05264,
  sequence = {APIIRRIPYYPEVESDLRIVDCKRSEGFCQEYCNYLETQVGYCSKKKDACCLH},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
references 1 papers
[1] source scaffold
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use